Polypharmacy Risk Screening
Polypharmacy Risk Screening is a systematic assessment method designed to identify individuals at increased risk of adverse health outcomes due to the concurrent use of multiple medications, distinguished by its focus on detecting potentially inappropriate prescribing, drug-drug interactions, and medication burden in clinical or research settings.
125
Publications
9.2K
Citations
708
Authors
362
Institutions
Publications per year
2017–2026
63
Parents
125
Danijela Gnjidic, Sarah N. Hilmer, Fiona Blyth et al. · Journal of Clinical Epidemiology · 2012 · 1.2K citations
Polypharmacy Status as an Indicator of Mortality in an Elderly Population
Johanna Jyrkkä, Hannes Enlund, Maarit Jaana Korhonen et al. · Drugs & Aging · 2009 · 357 citations
1–5 of 125
708
3
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 708
362
University of Tsukuba
Tsukuba, Japan
6 h-index
21 publications
600 citations

University of Rostock
Rostock, Germany
4 h-index
14 publications
553 citations
Columbia University
New York, United States
3 h-index
5 publications
583 citations

University of Oslo
Oslo, Norway
3 h-index
5 publications
611 citations

Monash University
Melbourne, Australia
3 h-index
9 publications
1.1K citations
Madrid Health Service
Madrid, Spain
3 h-index
9 publications
477 citations
Inserm
Paris, France
3 h-index
8 publications
351 citations

University of Toronto
Toronto, Canada
3 h-index
10 publications
361 citations
1–8 of 362
Repository · 5 publications · 544 citations
5
h-index
5 publications · 687 citations
5
h-index
4 publications · 257 citations
4
h-index
3 publications · 92 citations
3
h-index
3 publications · 140 citations
3
h-index
1–5